Previous close | 20.69 |
Open | 20.46 |
Bid | 19.70 x 1100 |
Ask | 19.99 x 3000 |
Day's range | 19.45 - 20.73 |
52-week range | 15.50 - 24.75 |
Volume | |
Avg. volume | 2,189,628 |
Market cap | 6.251B |
Beta (5Y monthly) | 0.78 |
PE ratio (TTM) | 27.07 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
The stock market continues to be under pressure due to geopolitical tensions and various economic problems. For instance, cancer-focused biotech company Exelixis (NASDAQ: EXEL) has run circles around the broader market year to date. Can Exelixis continue beating the market from here on out?
The stock market is highly volatile now. Robotic-assisted surgery is the future of surgery, and Intuitive Surgical (NASDAQ: ISRG) is already dominating the space. Biotech company Exelixis (NASDAQ: EXEL) and internet retail company Etsy (NASDAQ: ETSY) also have remarkable growth prospects that could bring in some exciting long-term returns.
With its stock down 11% over the past month, it is easy to disregard Exelixis (NASDAQ:EXEL). But if you pay close...